Evidence map›Paper›PMID 40825845›Full record

ArticleBJC reports2025

Hidden costs and unmet supportive care needs among individuals with experience of breast cancer and their carers in the United Kingdom.

Szeyi Ng, Lucy S Kilburn, Hilary Stobart, Lesley Stephen, Indrani S Bhattacharya, David A Cameron, Rebecca Lewis, Stuart A McIntosh, Carlo Palmieri, Catherine Towns and 2 more

Abstract read
In one paragraph

Article in BJC reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Szeyi Ng *Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, UK. Szeyi.ng@icr.ac.uk.ORCID http://orcid.org/0000-0002-7191-709X
Lucy S Kilburn *Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, UK.
Hilary StobartIndependent Cancer Patients' Voice, London, UK.
Lesley StephenMake 2nds Count, Edinburgh, UK.
Indrani S BhattacharyaCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
David A CameronUniversity of Edinburgh Cancer Centre, Institute of Genetics and Cancer, Edinburgh, UK.
Rebecca LewisClinical Trials and Statistics Unit at The Institute of Cancer Research, London, UK.
Stuart A McIntoshPatrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
Carlo PalmieriInstitute of Systems, Molecular and Integrative Biology, Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK.
Catherine TownsUniversity of Cambridge, Cambridge, UK.
Charlotte E Coles *Department of Oncology, University of Cambridge, Cambridge, UK.
Judith M Bliss *Clinical Trials and Statistics Unit at The Institute of Cancer Research, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe impact of cancer transcends physical health, affecting mental wellbeing, financial stability, and ability to perform daily tasks, influencing not only patients but also the broader community.

methodsOnline anonymous surveys (24/01/2023-03/03/2023) were disseminated via charities to individuals treated for breast cancer in the UK and their carers. Multivariable ordered logistic regression models were used to investigate demographic, cancer-related and employment factors associated with physical, wellbeing and financial Quality-of-Life (QoL).

results470 and 136 participants reported primary (PBC) and metastatic (MBC) breast cancer, respectively. 27% PBC and 35% MBC participants reported experience of financial problems. 17% PBC and 47% MBC participants reported trouble fulfilling caring responsibilities at the time of survey completion. For PBC participants, reports of financial problems were associated with difficulties seeking help for physical or wellbeing issues, which were associated with worse physical and wellbeing QoL. Financial problems, and other challenges were more commonly reported among MBC participants. These factors may impact QoL similarly, so there was no evidence of specific explanatory factors for MBC participants.

conclusionsBetter understanding of wider impact of breast cancer could lead to better policy and support. Future clinical trials should incorporate more comprehensive assessment of breast cancer's wider effects.

Identifiers

PMID40825845
PMCPMC12361448

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.